Peter Douglas Lockhard - Net Worth and Insider Trading

Peter Douglas Lockhard Net Worth

The estimated net worth of Peter Douglas Lockhard is at least $2 Million dollars as of 2024-11-09. Peter Douglas Lockhard is the Director of Biosyent Inc and owns about 177,929 shares of Biosyent Inc (TSXV:RX) stock worth over $2 Million. Details can be seen in Peter Douglas Lockhard's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Peter Douglas Lockhard has not made any transactions after 2024-09-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Peter Douglas Lockhard

To

Peter Douglas Lockhard Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Peter Douglas Lockhard owns 1 companies in total, including Biosyent Inc (TSXV:RX) .

Click here to see the complete history of Peter Douglas Lockhard’s form 4 insider trades.

Insider Ownership Summary of Peter Douglas Lockhard

Ticker Comapny Transaction Date Type of Owner
TSXV:RX Biosyent Inc 2024-09-23 Director

Peter Douglas Lockhard Latest Holdings Summary

Peter Douglas Lockhard currently owns a total of 1 stock. Peter Douglas Lockhard owns 177,929 shares of Biosyent Inc (TSXV:RX) as of September 23, 2024, with a value of $2 Million.

Latest Holdings of Peter Douglas Lockhard

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TSXV:RX Biosyent Inc 2024-09-23 177,929 11.15 1,983,908

Holding Weightings of Peter Douglas Lockhard


Peter Douglas Lockhard Form 4 Trading Tracker

According to the SEC Form 4 filings, Peter Douglas Lockhard has made a total of 3 transactions in Biosyent Inc (TSXV:RX) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Biosyent Inc is the sale of 600 shares on September 23, 2024, which brought Peter Douglas Lockhard around $6,660.

Insider Trading History of Peter Douglas Lockhard

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Peter Douglas Lockhard Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Peter Douglas Lockhard Ownership Network

Ownership Network List of Peter Douglas Lockhard

No Data

Ownership Network Relation of Peter Douglas Lockhard

Insider Network Chart

Peter Douglas Lockhard Owned Company Details

What does Biosyent Inc do?

Who are the key executives at Biosyent Inc?

Peter Douglas Lockhard is the Director of Biosyent Inc. Other key executives at Biosyent Inc include Senior Officer Sharan Raghubir , 10% Security Holder & Director & Senior Officer Rene Goehrum , and Issuer BioSyent Inc. .

Biosyent Inc (TSXV:RX) Insider Trades Summary

Over the past 18 months, Peter Douglas Lockhard made 3 insider transaction in Biosyent Inc (TSXV:RX) with a net sale of 1,235. Other recent insider transactions involving Biosyent Inc (TSXV:RX) include a net sale of 6,304 shares made by Seyed Ahmad Ashrafi , a net sale of 5,505 shares made by Sharan Raghubir , and a net sale of 1,522 shares made by Rene Goehrum .

In summary, during the past 3 months, insiders sold 5,939 shares of Biosyent Inc (TSXV:RX) in total and bought 0 shares, with a net sale of 5,939 shares. During the past 18 months, 14,566 shares of Biosyent Inc (TSXV:RX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 14,566 shares.

Biosyent Inc (TSXV:RX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Biosyent Inc Insider Transactions

No Available Data

Peter Douglas Lockhard Mailing Address

Above is the net worth, insider trading, and ownership report for Peter Douglas Lockhard. Currently GuruFocus does not have mailing address information for Peter Douglas Lockhard.